Mutual Funds Sahi Hai!
To avail the service, you will be redirected to loans.geojitcredits.com
Divis Laboratories Ltd is down for a fifth straight session today. The stock is quoting at Rs 9175.5, down 0.79% on the day as on 13:19 IST on the NSE. The benchmark NIFTY is up around 0.25% on the day, quoting at 22478.35. The Sensex is at 72073.15, up 0.23%.Divis Laboratories Ltd has lost around 1.5% in last one month.Meanwhile, Nifty Pharma index of which Divis Laboratories Ltd is a constituent, has eased around 2.14% in last one month and is currently quoting at 26311.55, down 0.79% on the day. The volume in the stock stood at 2.71 lakh shares today, compared to the daily average of 5.21 lakh shares in last one month.
The benchmark October futures contract for the stock is quoting at Rs 9215, down 0.56% on the day. Divis Laboratories Ltd jumped 57.48% in last one year as compared to a 10.37% slide in NIFTY and a 19.85% spurt in the Nifty Pharma index.
The PE of the stock is 82.36 based on TTM earnings ending June 26.
Divis Laboratories Ltd is down for a fifth straight session today. The stock is quoting at Rs 9108.5, down 0.97% on the day as on 13:19 IST on the NSE. The benchmark NIFTY is up around 0.65% on the day, quoting at 23269.55. The Sensex is at 74441.9, up 0.59%.Divis Laboratories Ltd has added around 7.39% in last one month.Meanwhile, Nifty Pharma index of which Divis Laboratories Ltd is a constituent, has eased around 0.81% in last one month and is currently quoting at 26188.4, down 0.23% on the day. The volume in the stock stood at 5.56 lakh shares today, compared to the daily average of 4.44 lakh shares in last one month.
The benchmark September futures contract for the stock is quoting at Rs 9126.5, down 0.75% on the day. Divis Laboratories Ltd jumped 50.52% in last one year as compared to a 8.14% slide in NIFTY and a 17.48% spurt in the Nifty Pharma index.
The PE of the stock is 81.44 based on TTM earnings ending June 26.
Revenue from operations grew 27.80% YoY to Rs 3,080 crore in Q1 FY27 from Rs 2,410 crore in Q1 FY26.
Profit before tax (PBT) stood at Rs 1,180 crore, up 60.98% YoY from Rs 733 crore in the corresponding quarter last year.
Total expenses rose 9.35% YoY to Rs 1,964 crore in Q1 FY27. The cost of materials consumed increased 48.81% YoY to Rs 1,503 crore, while employee benefit expenses rose 20% YoY to Rs 408 crore.
On a standalone basis, the company reported a 59.96% YoY increase in net profit to Rs 891 crore for the quarter ended 30 June 2026, compared with Rs 557 crore in the corresponding quarter last year. Total income rose 22.66% YoY to Rs 3,037 crore in Q1 FY27 from Rs 2,476 crore in Q1 FY26.
The board approved the appointment of B. Vara Prasad, General Manager (Engineering Purchase), and J. Srinivasa Rao, General Manager (Raw Materials Purchase), as Senior Management Personnel with effect from 1 August 2026.
Vara Prasad has been associated with the company since 1994 and has over 31 years of experience in the pharmaceutical industry. He oversees engineering-related procurement and has expertise in strategic sourcing, vendor management, contract negotiations, capital equipment procurement, and execution of large-scale manufacturing projects.
Srinivasa Rao joined the company in 1995 and has over 30 years of experience in pharmaceutical procurement. He is responsible for end-to-end raw material sourcing and has expertise in strategic sourcing, vendor development, contract negotiations, regulatory compliance, and supply chain management.
Divi's Laboratories is engaged in the manufacture of active pharmaceutical ingredients (APIs), intermediates and nutraceutical ingredients.
Shares of Divi's Laboratories rose 2.76% to close at Rs 8,056.65 on Friday, 31 July 2026.
Divis Laboratories Ltd gained for a fifth straight session today. The stock is quoting at Rs 8029, up 2.48% on the day as on 12:44 IST on the NSE. The benchmark NIFTY is up around 0.35% on the day, quoting at 24401.75. The Sensex is at 78202.2, up 0.35%. Divis Laboratories Ltd has gained around 22.66% in last one month.
Meanwhile, Nifty Pharma index of which Divis Laboratories Ltd is a constituent, has gained around 5.81% in last one month and is currently quoting at 26346.05, up 1.14% on the day. The volume in the stock stood at 4.85 lakh shares today, compared to the daily average of 4.72 lakh shares in last one month.
The benchmark August futures contract for the stock is quoting at Rs 8055, up 2.5% on the day. Divis Laboratories Ltd is up 26.21% in last one year as compared to a 0.67% slide in NIFTY and a 21.06% slide in the Nifty Pharma index.
The PE of the stock is 78.18 based on TTM earnings ending March 26.
Divis Laboratories Ltd gained for a third straight session today. The stock is quoting at Rs 7750.5, up 4.38% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is up around 0.94% on the day, quoting at 24210.65. The Sensex is at 77537, up 1%. Divis Laboratories Ltd has risen around 17.81% in last one month.
Meanwhile, Nifty Pharma index of which Divis Laboratories Ltd is a constituent, has risen around 3.98% in last one month and is currently quoting at 25998.85, up 1.29% on the day. The volume in the stock stood at 5.86 lakh shares today, compared to the daily average of 4.36 lakh shares in last one month.
The benchmark August futures contract for the stock is quoting at Rs 7772.5, up 4.24% on the day. Divis Laboratories Ltd is up 16.55% in last one year as compared to a 2.59% drop in NIFTY and a 14.13% drop in the Nifty Pharma index.
The PE of the stock is 73.99 based on TTM earnings ending March 26.
Divis Laboratories Ltd rose for a fifth straight session today. The stock is quoting at Rs 7296, up 1.5% on the day as on 12:44 IST on the NSE. The benchmark NIFTY is up around 0.45% on the day, quoting at 24160.1. The Sensex is at 77455.4, up 0.52%. Divis Laboratories Ltd has added around 8.69% in last one month.
Meanwhile, Nifty Pharma index of which Divis Laboratories Ltd is a constituent, has added around 7.92% in last one month and is currently quoting at 25907.1, up 0.64% on the day. The volume in the stock stood at 4.33 lakh shares today, compared to the daily average of 3.82 lakh shares in last one month.
The benchmark July futures contract for the stock is quoting at Rs 7265.5, up 1.25% on the day. Divis Laboratories Ltd is up 6.81% in last one year as compared to a 4.17% fall in NIFTY and a 15.39% fall in the Nifty Pharma index.
The PE of the stock is 71.64 based on TTM earnings ending March 26.